Geographic and Temporal Variability of Hepatitis E Virus Circulation in the Russian FederationArticle Published on 2022-12-222023-06-11 Journal: Viruses [Category] E형 간염, Fulltext, [키워드] disease outbreaks hepatitis E virus Molecular epidemiology Paslahepevirus balayani Seroprevalence zoonosis. [DOI] 10.3390/v15010037 PMC 바로가기
SARS-CoV-2 antibody seroprevalence in Togo: a national cross-sectional household survey, May-June, 2021Article Published on 2022-12-082023-07-11 Journal: BMC Public Health [Category] COVID19(2023년), [키워드] General population SARS-CoV-2 Seroprevalence Togo. [DOI] 10.1186/s12889-022-14794-2 PMC 바로가기
Repertoires of SARS-CoV-2 epitopes targeted by antibodies vary according to severity of COVID-19코로나19 중증도에 따라 항체 표적 SARS-CoV-2 에피토프 레퍼토리 달라Article Published on 2022-12-012022-09-11 Journal: Virulence [Category] COVID19(2023년), SARS, 진단, 치료법, [키워드] antibodies antibody Antigen association Asymptomatic asymptomatic individual asymptomatic infection betacoronavirus Betacoronavirus Community convalescent correlated COVID-19 COVID-19 severity develop diagnosed diagnostics disease severity domains Epitopes Evidence evidence of finding FIVE five groups HKU1 Hospitalization IgG IgGs Immunity immunogenic immunogenic peptide individual Infection less MERS-CoV nucleocapsid protein Nucleocapsid proteins OC43 participant pathogenic pathogenic mechanisms peptide peptide array peptides pilot study predicted Protein RBDs reaction Receptor binding domain Region repertoire SARS-CoV RBD SARS-CoV RBDs SARS-CoV-2 SARS-CoV-2 epitope SARS-CoV-2 epitopes seroconverted Seroprevalence seroprevalence. severity severity of COVID-19 symptomatic symptomatic COVID-19 symptomatic infection therapeutic therapeutic antibodies Vaccines Viral with COVID-19 without symptoms [DOI] 10.1080/21505594.2022.2073025 PMC 바로가기 [Article Type] Article
Seroprevalence of SARS-CoV-2 in German secondary schools from October 2020 to July 2021: a longitudinal studyArticle Published on 2022-12-012023-07-08 Journal: Infection [Category] COVID19(2023년), [키워드] Infectious disease pediatrics SARS-CoV-2 Seroprevalence students teachers. [DOI] 10.1007/s15010-022-01824-9 PMC 바로가기
Prevalence and Correlates of SARS CoV-2 Among a Community-Based Sample Recruited Using Randomized Venue-Based Sampling. Essex County, NJ, 2020Article Published on 2022-12-012022-11-15 Journal: Journal of racial and ethnic health disparities [Category] COVID19(2023년), SARS, 진단, [키워드] antibody black blood sample Care Community conducted correlates COVID-19 death determine Diagnosis disease Disparities disparity Factor help identify Infection Latinx morbidity and mortality New no significant difference outcome participant Participants PCR testing positive Prevalence provided public health reflected Sample sampling SARS CoV-2 SARS-CoV-2 antibodies Seroprevalence seroprevalence. stick suggested Surveillance Testing the disease Treatment underlying conditions upstream USA virus [DOI] 10.1007/s40615-021-01175-5 PMC 바로가기
Pre-Vaccination Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Seroprevalence in Workers at Three Japanese HospitalsObservational Study Published on 2022-11-092023-07-09 Journal: Journal of Nippon Medical School = Nippon Ika Daigaku zasshi [Category] COVID19(2023년), [키워드] Anti-severe acute respiratory syndrome coronavirus 2 antibody coronavirus disease Healthcare workers Seroprevalence university hospitals. [DOI] 10.1272/jnms.JNMS.2022_89-511 PMC 바로가기 [Article Type] Observational Study
Prevalence of antibodies against SARS-CoV-2 in the Norwegian population, August 2021Article Published on 2022-11-012022-11-15 Journal: Influenza and Other Respiratory Viruses [Category] COVID19(2023년), SARS, 진단, [키워드] absence age Anti-nucleocapsid antibodies antibody automatically children collected conducted confirmed COVID-19 case contributed COVID-19 COVID-19 case COVID-19 pandemic COVID-19 vaccination CrI cross-sectional cumulative estimate Estimated flow cytometric IgG antibody individual Infection Laboratory National Norway nucleocapsid nucleocapsid protein Prevalence RBD Receptor binding domain registry data residual SARS-CoV-2 SARS-CoV-2 antibody SARS-COV-2 infection SARS-CoV-2 seroprevalence sera seropositive sample Seroprevalence the spike protein vaccination vaccination. were measured women [DOI] 10.1111/irv.13024 PMC 바로가기
SARS-CoV-2 seroprevalence in healthcare workers and risk factorsArticle Published on 2022-11-012023-07-09 Journal: Infection, disease & health [Category] COVID19(2023년), [키워드] healthcare worker SARS-CoV-2 Seroprevalence smoking. [DOI] 10.1016/j.idh.2022.05.002 PMC 바로가기
Seroprevalence of infection-induced SARS-CoV-2 antibodies among health care users of Northern Italy: results from two serosurveys (October-November 2019 and September-October 2021)Article Published on 2022-11-012022-11-15 Journal: International Journal of Infectious Diseases [Category] SARS, 진단, 치료기술, [키워드] 95% CI 95% confidence interval age anti-Nucleocapsid IgG antibodies antibody calculated Care circulating CIs conducted COVID-19 detect domains enzyme-linked immunosorbent enzyme-linked immunosorbent assay Gender groups Health Hypothesis IgG IgG antibody Immunoglobulin immunosorbent Italy multiplex nucleocapsid Piedmont positive test result prevalence rate proportion Receptor binding domain Result S1 and S2 S1 domain Sample SARS-CoV-2 SARS-CoV-2 antibody semiquantitative method sera Seroprevalence seroprevalence. Serosurvey Support tested the spike protein Transmission dynamics virus [DOI] 10.1016/j.ijid.2022.09.017 PMC 바로가기
Age-Stratified Seroprevalence of SARS-CoV-2 Antibodies before and during the Vaccination Era, Japan, February 2020-March 2022Article Published on 2022-11-012022-11-15 Journal: Emerging Infectious Diseases [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] acute respiratory syndrome administration age antibody Area caused children collected coronavirus coronavirus disease COVID-19 COVID-19 cases Delta diagnostic test Effect eligible Epidemiology Immunity incidence Infection infections Japan omicron population level receive reported respiratory infections SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 seroprevalence seropositive Seroprevalence severe acute respiratory syndrome coronavirus 2 Spread the epidemic the SARS-CoV-2 Tokyo vaccination vaccination rate Vaccine vaccine-preventable diseases variants viruses zoonoses zoonoses. [DOI] 10.3201/eid2811.221127 PMC 바로가기